Angiography – Merge Technologies Will Continue to Be Listed on NASDAQ Pending Final Determination by NASDAQ Panel (SYS-CON Media)
Merge Technologies Will Continue to Be Listed on NASDAQ Pending Final Determination by NASDAQ Panel (SYS-CON Media)
Merge Technologies Incorporated, d.b.a. Merge Healthcare (Nasdaq: MRGE; TSX: MRG), today announced that the Company has been informed by the staff of The NASDAQ Stock Market that the NASDAQ Listing Qualifications Panel’s review of the Company’s status as a NASDAQ-listed company is ongoing and that the Company’s common stock will continue to be listed on the NASDAQ National Market until at least
Now, angiography test to cost less at VS Hospital – Ahmedabad Newsline
| Now, angiography test to cost less at VS Hospital Ahmedabad Newsline, India - Charges for carrying out angiography at the Vadilal Sarabhai General Hospital will be slashed further from the current rates, which are almost at par with … |
marketgainer.com: Updates on Merge Technologies Inc
Stockhouse Canada – Cedara technologies and expertise span all the major digital imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), digital X-ray, mammography, ultrasound, echo-cardiology, angiography, nuclear medicine, positron …
Medical Ventures’ New Cardiology Device Receives European Regulatory Approval (T-Net British Columbia)
Vancouver, BC, July 10, 2006–(T-Net)–MEDICAL VENTURES CORP announced it has received European CE Mark approval for its Metricath Gemini balloon-catheter product.
Medical Ventures Corp.: New Cardiology Device Receives European … – CCNMatthews (press release)
| Medical Ventures Corp.: New Cardiology Device Receives European … CCNMatthews (press release), Canada - … requires multiple catheters to perform the two functions, or often relies on doctors estimating vessel size and stent expansion using angiography imaging. … |